Symbol: |
VLDLR
|
Description: |
very low density lipoprotein receptor [Source:HGNC Symbol;Acc:12698]
|
Location: |
Chr9:2621834-2654480[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:349
Gene |
Compound |
Gen_sig |
Exp_pattern |
VLDLR |
Pyridone-OCH3 |
0.004 |
Down |
VLDLR |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.042 |
Up |
VLDLR |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.001 |
Up |
VLDLR |
ARTEMISININ DIMER HEMISUCCINATE |
0.033 |
Up |
VLDLR |
4,11-dihydroxy-1-[4-(4-hydroxy-1-piperidinyl)butyl]-1H-napht ho[2,3-f]indole-5,10-dione |
0.035 |
Up |
VLDLR |
NSC 732719 |
0.027 |
Up |
VLDLR |
Everolimus |
0.001 |
Down |
VLDLR |
NSC 734201 |
0.04 |
Down |
VLDLR |
NSC 734631 |
0.037 |
Up |
VLDLR |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.001 |
Down |
VLDLR |
NSC 736104 |
0.045 |
Up |
VLDLR |
NSC 736154 |
0.001 |
Up |
VLDLR |
7-(2-Pyrrolidinoethyl)oximino-5-androsten-3b,17b-diol diacetate |
0.006 |
Up |
VLDLR |
1-(4-chlorophenyl)-3,3-diphenyl-1'-methylspiro[azetidin-2,3' =indoline]=2',4-dione |
0.018 |
Up |
VLDLR |
(-)-dactylolide |
0.001 |
Up |
Expression pattern: Sensitivity / Resistance
Total:24 Current:22
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:15
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:163
Total:11 Current:1
[First] [Prev]  Next Last 
|